Comparative efficacy and safety analysis of CSE-1034: An open labeled phase III study in community acquired pneumonia

Objective: CSE-1034 is a novel antibiotic adjuvant entity (AAE) with proven activity against broad range of multi-drug resistant (MDR) pathogens causing various bacterial infections. This phase 3 clinical trial was designed to evaluate the efficacy and safety of CSE-1034 therapy for the treatment of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Manu Chaudhary (Autor), Shiekh G. Ayub (Autor), Mohd A. Mir (Autor)
Formato: Libro
Publicado: Elsevier, 2018-09-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible